Limiting cefotaxime pediatric dosing to adult standards: A pharmacokinetic simulation study

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 6, 1999, Pages 269-274

  Lopez, A M Dulaney ^a,c   Rodriguez, J C ^a,b   Lopez Samblas, A M ^a,b   Estes, K S ^b  

^a UNIVERSITY OF MIAMI   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c ST LUKE S MEDICAL CENTER   (United States)

Author keywords

Cefotaxime dosing; Pediatrics; Pharmacokinetics

Indexed keywords

CEFOTAXIME;

AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CHILD; CLINICAL TRIAL; COMPUTER SIMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; META ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; PEDIATRICS; PRESCHOOL CHILD; SCHOOL CHILD;

ADULT; AREA UNDER CURVE; CEFOTAXIME; CEPHALOSPORINS; CHILD; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROBIAL SENSITIVITY TESTS; REFERENCE STANDARDS;

EID: 0344348870     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. American Academy of Pediatrics 1997 Antimicrobials and related therapy. In: Peter G (ed) Red Book: Report of the Committee on Infectious Diseases (24th ed). American Academy of Pediatrics, Elk Grove Village, IL, pp 610
2. Barone MA 1996 The Harriet Lane Handbook (14th ed). Mosby, St. Louis, pp 500-501
3. Craig WA 1995 Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis 22: 89-96
4. Dalla Costa T, Derendorf H 1996 AUIC - A general target for the optimization of dosing regimens of antibiotics? Ann Pharmacother 30: 1024-1028
5. Heinman G, Seeger K 1980 Pharmacokinetics and clinical data of cefotaxime in children. Chemioter Antimicrob 3 (Suppl 2): 42
6. Hoechst-Roussel Pharmaceuticals 1996 Claforan package insert. Somerville, NJ
7. Ings RMJ, Fillastre J-P, Godin M et al 1982 The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function. Rev Infect Dis 4 (Suppl): S379-391
8. Jacobs RF, Darville T, Parks JA, Enderlin G 1992 Safety profile and efficacy of cefotaxime for the treatment of hospitalized children. Clin Infect Dis 14: 56-65
9. Jones RN 1995 Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review. Diagn Microbiol Infect Dis 22: 19-33
10. Jordan NS, Shyu WC, Quintiliani R, Nightingale CH 1986 Comparative pharmacokinetics of ceftizoxime and cefotaxime in healthy volunteers. Curr Ther Res 40: 133-139
11. Kafetzis DA, Kanarios J, Sinaniotis CA, Papadatos CJ 1979 Clinical and pharmacokinetic study of cefotaxime (HR-756) in infants and children. 11th Int Congr Chemother And 19th Intersci Conf On Antimicrob Agents and Chemother, Boston, Mass 1-5 Oct 1979 Washington. Am Soc Microbiol, Abstract 873
12. Karchmer AW 1995 Cephalosporins. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and Practice of Infectious Diseases. Churchill Livingstone, New York, pp 255
13. Kearns GL, Young RA, Jacobs RF 1992 Cefotaxime dosage in infants and children: pharmacokinetic and clinical rationale for an extended dosage intervall. Clin Pharmacokinet 22: 284-297
14. Kearns GL, Young RA 1995 Pharmacokinetics of cefotaxime and desacetylcefotaxime in the young. Diagn Microbiol Infect Dis 22: 97-104
15. Klein NC, Cunha BA 1995 Third-generation cephalosporins. Med Clin North Am 79: 705-719
16. Kucers A, Crowe S, Grayson ML, Hoy J 1997 Cefotaxime, Cefoperazone, Ceftizoxime and Cefsulodin. In: Kucers A, Crowe S, Grayson ML, Hoy J (eds) The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, and Antiviral Drugs. Butterworth-Heinemann, Boston, pp 331
17. Lambert-Zechovsky N, Aufrant C, Bingen E, Blum C, Proux MC, Mathieu H 1980 Cefotaxime in children: efficacy, tolerance and effect on the intestinal flora. J Antimicrob Chemother 6: 235-242
18. Neu HC, Aswapokee P, Fu KP et al 1980 Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses. Clin Pharmacol Ther 27: 677-685
19. Taketomo CK, Hodding JH, Kraus DM 1997 Pediatric Dosage Handbook (4th ed). Lexi-Comp Inc, Hudson, pp 135-136
20. Trang JM, Jacobs RF, Kearns GL et al 1985 Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimicrob Agents Chemother 28: 791-795
21. Varghese M, Khan AJ, Kumar K Evans HE 1982 Clinical and pharmacokinetic evaluation of cefotaxime in infants and children. Pediatr Res 16: Abstract 1045